Pendi, Asmihan .

HRN: 18-80-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/12/2025
10/19/2025
IV
375mg
Q6
Uti
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: